- Home
- OCEA vs HOOK Comparison
OCEA vs HOOK Comparison
Compare OCEA & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEA
- HOOK
- Stock Information
- Founded
- OCEA 2019
- HOOK 2011
- Country
- OCEA United States
- HOOK United States
- Employees
- OCEA N/A
- HOOK N/A
- Industry
- OCEA Biotechnology: Pharmaceutical Preparations
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- OCEA Health Care
- HOOK Health Care
- Exchange
- OCEA Nasdaq
- HOOK Nasdaq
- Market Cap
- OCEA 20.5M
- HOOK 24.5M
- IPO Year
- OCEA N/A
- HOOK 2019
- Fundamental
- Price
- OCEA $0.54
- HOOK $1.95
- Analyst Decision
- OCEA
- HOOK Buy
- Analyst Count
- OCEA 0
- HOOK 4
- Target Price
- OCEA N/A
- HOOK $10.67
- AVG Volume (30 Days)
- OCEA 617.7K
- HOOK 265.8K
- Earning Date
- OCEA 01-13-2025
- HOOK 11-14-2024
- Dividend Yield
- OCEA N/A
- HOOK N/A
- EPS Growth
- OCEA N/A
- HOOK N/A
- EPS
- OCEA N/A
- HOOK N/A
- Revenue
- OCEA N/A
- HOOK $49,999,000.00
- Revenue This Year
- OCEA N/A
- HOOK $147.52
- Revenue Next Year
- OCEA N/A
- HOOK N/A
- P/E Ratio
- OCEA N/A
- HOOK N/A
- Revenue Growth
- OCEA N/A
- HOOK 143.30
- 52 Week Low
- OCEA $0.46
- HOOK $1.72
- 52 Week High
- OCEA $7.79
- HOOK $10.50
- Technical
- Relative Strength Index (RSI)
- OCEA 40.01
- HOOK 43.79
- Support Level
- OCEA $0.53
- HOOK $1.80
- Resistance Level
- OCEA $0.70
- HOOK $1.99
- Average True Range (ATR)
- OCEA 0.08
- HOOK 0.24
- MACD
- OCEA -0.00
- HOOK 0.04
- Stochastic Oscillator
- OCEA 4.31
- HOOK 21.66
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.